Overview

Combining Varenicline and Guanfacine for Smoking Cessation

Status:
Recruiting
Trial end date:
2024-08-31
Target enrollment:
Participant gender:
Summary
The novel design of this study combines a laboratory paradigm to evaluate stress-induced smoking behavior and smoking-related reinforcement, followed by a 12-week treatment phase to evaluate clinical outcomes.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Guanfacine
Varenicline